Progyny Inc (NAS:PGNY)
$ 23.261 0.35 (1.53%) Market Cap: 2.10 Bil Enterprise Value: 1.82 Bil PE Ratio: 36.30 PB Ratio: 4.55 GF Score: 80/100

Progyny Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 08:40PM GMT
Release Date Price: $45.02 (+0.24%)
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good afternoon. My name is Lisa Gill, and I am the health care technology and distribution analyst of JPMorgan. This afternoon, I'm filling in for my colleague, Annie Samuel, who all of you know recently had a baby.

I am incredibly happy to have with us this afternoon, Progyny, a name she really likes and one that she could completely attest to. With me this afternoon is CEO, David Schlanger; President and COO, Peter Anevski; as well as CFO, Mark Livingston. David's going to kick it off with a presentation, and then we're going to come back and bring Pete and Mark back for the Q&A. So David, thanks so much for joining us. David, you're actually on mute.

David J. Schlanger
Progyny, Inc. - CEO & Director

Here we go. Thanks, Lisa, for that introduction, and thank you, everybody, for joining us today. As Lisa said, I'm going to walk you through our presentation, and afterwards,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot